Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Meyers James R Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/05/2023 4 Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 13,900 shares @ $0
Granted 27,750 options to buy @ $1.11, valued at $30.8k
05/26/2023 4 Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 55,000 options to buy @ $0
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2020 4 Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 22,000 options @ $0
05/20/2020 4 Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 2,500 shares @ $0
Granted 15,000 options to buy @ $10.46, valued at $156.9k
11/26/2019 4 Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $9.81, valued at $294.3k
08/20/2019 4 Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 22,000 options @ $0
06/21/2019 4 Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 14,000 options to buy @ $11.31, valued at $158.3k
12/27/2018 4 Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 28,000 options to buy @ $14.04, valued at $393.1k
10/22/2018 4 Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 44,000 options to buy @ $4.71, valued at $207.2k
02/23/2018 4 Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC
Txns: Granted 221 shares @ $62.3475, valued at $13.8k
Granted 4,846 shares @ $0
Granted 1,581 shares @ $0
Paid exercise price by delivering 1,647 shares @ $80.69, valued at $132.9k
Gifted 2,323 shares @ $0
Gifted 2,323 shares @ $0
02/05/2018 4 Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC
Txns: Granted 75,490 options to buy @ $83.49, valued at $6.3M
01/18/2018 4 Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC
Txns: Sold 75,157 shares @ $79.9961, valued at $6M
Sold 24,843 shares @ $80.9925, valued at $2M
Exercised 100,000 options to buy @ $21.575, valued at $2.2M
11/13/2017 4 Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC
Txns: Granted 2,700 shares @ $0
Paid exercise price by delivering 1,373 shares @ $73.02, valued at $100.3k
Gifted 1,327 shares @ $0
Gifted 1,327 shares @ $0
11/07/2017 4 Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC
Txns: Paid exercise price by delivering 2,212 shares @ $73.46, valued at $162.5k
Gifted 2,288 shares @ $0
Gifted 2,288 shares @ $0
Exercised 4,500 restricted stock units @ $0
09/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/13/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy